Table 2.
Types of antibiotic regimen (n = 90) divided into monotherapy and combination therapy
| Antibiotic (International drug name) | N (%) |
|---|---|
| Monotherapy | |
| Amoxicillin-clavulanate | 20 |
| Piperacillin-tazobactam | 9 |
| Third-generation cephalosporin | 8 |
| Carbapenem | 6 |
| Fluoroquinolone | 5 |
| Amoxicillin | 4 |
| Glycopeptide | 1 |
| Other | 2 |
| TOTAL | 55 (61.1) |
| Combination therapy with 2 antibiotics | |
| Piperacillin-tazobactam + fluoroquinolone | 6 |
| Third-generation cephalosporin + other antibiotic | 6 |
| Amoxicillin-clavulanate + Fluoroquinolone | 4 |
| Third-generation cephalosporin + fluoroquinolone | 3 |
| Carbapenem + other antibiotic | 3 |
| Amoxicillin-clavulanate + other antibiotic | 3 |
| Piperacillin-tazobactam + tigecyclin | 1 |
| Piperacillin-tazobactam + antibiotic active against MRSAa | 2 |
| Fluoroquinolone + rifampin | 1 |
| TOTAL | 29 (32.2) |
| Combination therapy with 3 or more antibiotics | |
| Carbapenem + fluoroquinolone + aminoglycoside | 2 |
| Pipera-tazobactam + fluoroquinolone + aminoglycoside | 1 |
| Carbapenem + colistin + tigecyclin | 1 |
| Pipera-tazobactam + fluoroquinolone + linezolide | 1 |
| Carbapenem + colistin + glycopeptide | 1 |
| TOTAL | 6 (6.7) |
aMRSA: methicillin-resistant Staphylococcus aureus